Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors

Effective treatments for brain tumors remain one of the most urgent and unmet needs in modern oncology. This is due not only to the presence of the neurovascular unit/blood–brain barrier (NVU/BBB) but also to the heterogeneity of barrier alteration in the case of brain tumors, which results in what...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffith, Jessica I., Rathi, Sneha, Zhang, Wenqiu, Zhang, Wenjuan, Drewes, Lester R., Sarkaria, Jann N., Elmquist, William F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763839/
https://www.ncbi.nlm.nih.gov/pubmed/33322488
http://dx.doi.org/10.3390/pharmaceutics12121205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763839/
https://www.ncbi.nlm.nih.gov/pubmed/33322488
http://dx.doi.org/10.3390/pharmaceutics12121205

Ejemplares similares